ArticleTherapeutic advances in hematology2013

Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologist.

Arleigh R McCurdy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.